Reaction cycle of Thermotoga maritima copper ATPase and conformational characterization of catalytically deficient mutants.
Copper transport ATPases sustain important roles in homeostasis of heavy metals and delivery of copper to metalloenzymes. The copper transport ATPase from Thermotoga maritima (CopA) provides a useful system for mechanistic studies, due to its heterologous expression and stability. Its sequence comprises 726 amino acids, including the N-terminal metal binding domain (NMBD), three catalytic domains (A, N, and P), and a copper transport domain formed by eight helices, including the transmembrane metal binding site (TMBS). We performed functional characterization and conformational analysis by proteolytic digestion of WT and mutated (NMBD deletion or mutation) T. maritima CopA, comparing it with Archaeoglobus fulgidus CopA and Ca(2+) ATPase. A specific feature of T. maritima CopA is ATP utilization in the absence of copper, to form a low-turnover phosphoenzyme intermediate, with a conformation similar to that obtained by phosphorylation with P(i) or phosphate analogues. On the other hand, formation of an activated state requires copper binding to both NMBD and TMBS, with consequent conformational changes involving the NMBD and A domain. Proteolytic digestion analysis demonstrates A domain movements similar to those of other P-type ATPases to place the conserved TGES motif in the optimal position for catalytic assistance. We also studied an H479Q mutation (analogous to one of human copper ATPase ATP7B in Wilson disease) that inhibits ATPase activity. We found that, in spite of the H479Q mutation within the nucleotide binding domain, the mutant still binds ATP, yielding a phosphorylation transition state conformation. However, covalent phosphoryl transfer is not completed, and no catalytic turnover is observed.
California Pacific Medical Center Research Institute, San Francisco, California 94107, USA.
Yuta
Y
Hatori
David
D
Lewis
Chikashi
C
Toyoshima
Giuseppe
G
Inesi
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000235:genetics*; D000255:Adenosine Triphosphate / Q000172:deficiency; D019943:Amino Acid Substitution / Q000235:genetics; D001426:Bacterial Proteins / Q000737:chemistry* / Q000235:genetics* / Q000378:metabolism; D002384:Catalysis; D027682:Cation Transport Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000235:genetics*; D003300:Copper / Q000737:chemistry / Q000378:metabolism* / Q000502:physiology; D000073840:Copper-Transporting ATPases; D014644:Genetic Variation; D006527:Hepatolenticular Degeneration / Q000235:genetics; D006801:Humans; D016297:Mutagenesis, Site-Directed; D010766:Phosphorylation; D011487:Protein Conformation; D017434:Protein Structure, Tertiary / Q000235:genetics; D017384:Sequence Deletion; D020124:Thermotoga maritima / Q000201:enzymology* / Q000235:genetics*
D001426:Bacterial Proteins; D027682:Cation Transport Proteins; D003300:Copper; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases; C000612464:ATP7B protein, human; D000073840:Copper-Transporting ATPases